RANK/RANKL/OPG LIGAND-RECEPTOR SYSTEM AND ITS ROLE IN PRIMARY BONE NEOPLASMS (LITERATURE ANALYSIS AND OWN DATA)
Main Authors: | E. S. Gershtein, Yu. S. Timofeev, A. A. Zuev, N. E. Kushlinskii |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-12-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/45 |
Similar Items
-
COMPARATIVE ANALYSIS OF QUANTITATIVE COMPUTED TOMOGRAPHY DATA AND HISTOLOGICAL FINDINGS IN PATIENTS WITH GIANT CELL BONE TUMOR TREATED WITH DENOSUMAB
by: S. A. Tabakaev, et al.
Published: (2021-05-01) -
The first results of combined treatment of giant cell tumor of bone
by: A. A. Barashev, et al.
Published: (2020-11-01) -
ПАТОФИЗИОЛОГИЧЕСКАЯ РОЛЬ ОСТЕОПРОТЕГЕРИНА ПРИ АТЕРОСКЛЕРОЗЕ И САХАРНОМ ДИАБЕТЕ
by: A. R. Obukhovich, et al.
Published: (2022-05-01) -
Prognostic value of receptor activator of nuclear factor kappa-B (RANK) marker in patients with breast cancer
by: S. I. Zabroda, et al.
Published: (2015-07-01) -
OSTEOPROTEGERIN AS A PREDICTIVE MARKER OF THE COURSE OF BREAST CANCER
by: S. I. Zabroda, et al.
Published: (2015-04-01)